カテゴリー： IMARC, 世界, 医療/バイオ

うつ病治療薬の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測

◆英語タイトル：Depression Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
	◆商品コード：IMARC23JLY065 ◆発行会社（リサーチ会社）：IMARC ◆発行日：2023年7月 ◆ページ数：144 ◆レポート形式：英語 / PDF ◆納品方法：Eメール ◆調査対象地域：グローバル ◆産業分野：医療

◆販売価格オプション（消費税別）

Single User	USD2,999 ⇒換算￥449,850	見積依頼/購入/質問フォーム
Five User	USD3,999 ⇒換算￥599,850	見積依頼/購入/質問フォーム
Enterprisewide	USD4,999 ⇒換算￥749,850	見積依頼/購入/質問フォーム

★IMARCに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

アイマーク社の本調査レポートでは、2022年に62億ドルであった世界のうつ病治療薬市場規模が、2023年から2028年の間に年平均3.4％成長し、2028年には221億ドルに到達すると予測しています。本レポートでは、うつ病治療薬の世界市場について調査・分析し、序論、範囲・手法、エグゼクティブサマリー、イントロダクション、薬物クラス別（非定型抗精神病薬、セロトニン-ノルアドレナリン再取り込み阻害剤（SNRI）、選択的セロトニン再取り込み阻害剤（SSRI）、中枢神経系（CNS）興奮剤、その他）分析、障害種類別（大鬱病性障害、強迫性障害、全般性不安障害、パニック障害、その他）分析、薬物種類別（ジェネリック医薬品、ブランド医薬品）分析、流通チャネル別（病院薬局、小売薬局、オンライン薬局、その他）分析、地域別（北米、アジア太平洋、ヨーロッパ、中南米、中東・アフリカ）分析、SWOT分析、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況など、以下のようにまとめました。また、Otsuka Pharmaceutical, Pfizer, Eli Lilly and Company, AstraZeneca, Novartis, Bristol-Myers Squibb, GlaxoSmithKline, Takeda Pharmaceutical Company, Allergan, Johnson & Johnson, Zhejiang NHU Company Ltd and Sebela Pharmaceuticalsなどの企業情報を含んでいます。
・序論
・範囲・手法
・エグゼクティブサマリー
・イントロダクション
・世界のうつ病治療薬市場規模：薬物クラス別
- 非定型抗精神病薬の市場規模
- セロトニン-ノルアドレナリン再取り込み阻害剤（SNRI）の市場規模
- 選択的セロトニン再取り込み阻害剤（SSRI）の市場規模
- 中枢神経系（CNS）興奮剤の市場規模
- その他薬物クラスの市場規模
・世界のうつ病治療薬市場規模：障害種類別
- 大鬱病性障害における市場規模
- 強迫性障害における市場規模
- 全般性不安障害における市場規模
- パニック障害における市場規模
- その他障害における市場規模
・世界のうつ病治療薬市場規模：薬物種類別
- ジェネリック医薬品の市場規模
- ブランド医薬品の市場規模
・世界のうつ病治療薬市場規模：流通チャネル別
- 病院薬局チャネルの市場規模
- 小売薬局チャネルの市場規模
- オンライン薬局チャネルの市場規模
- その他流通チャネルの市場規模
・世界のうつ病治療薬市場規模：地域別
- 北米のうつ病治療薬市場規模
- アジア太平洋のうつ病治療薬市場規模
- ヨーロッパのうつ病治療薬市場規模
- 中南米のうつ病治療薬市場規模
- 中東・アフリカのうつ病治療薬市場規模
・SWOT分析
・バリューチェーン分析
・ファイブフォース分析
・価格分析
・競争状況

Market Overview:
The global depression drugs market size reached US$ 18.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 22.1 Billion by 2028, exhibiting a growth rate (CAGR) of 3.4% during 2023-2028.

Depression is a mental disorder characterized by the absence of positive emotions, constant low mood and numerous cognitive, physical, behavioral and emotional symptoms. It is diagnosed by identifying the symptoms and checking the medical history of the patient. It is then treated using depression drugs, which balance the functioning of neurotransmitters, such as serotonin, in the brain and controlling the mood and emotions of the patient. These drugs can assist in relieving the signs of anxiety, seasonal affective disorder and dysthymia.

According to the World Health Organization (WHO), depression is one of the leading causes of disability and has impacted more than 264 million people across the globe. The increasing prevalence of mental disorders, such as social anxiety and depression, represents one of the key factors propelling the depression drugs market growth. Moreover, as governments of various countries have imposed complete lockdown and are promoting the adoption of social distancing measures, the everyday routine of a significant portion of the population has been altered, which, in turn, has negatively impacted the mental health of individuals. This trend has emerged as another major growth-inducing factor boosting the sales of depression drugs. Furthermore, the emergence of novel techniques for the development of antidepressants with minimal side-effects and long-term results, in confluence with the increasing acceptance of new medications, is anticipated to impel the market growth in the upcoming years.

IMARC Group’s latest report provides a deep insight into the global depression drugs market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the depression drugs market in any manner.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global depression drugs market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on drug class, disorder type, drug type and distribution channel.

Breakup by Drug Class:
Atypical Antipsychotics
Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
Selective Serotonin Reuptake Inhibitors (SSRIs)
Central Nervous System (CNS) Stimulants
Tricyclic Antidepressants
Monoamine Oxidase Inhibitors
Others

Breakup by Disorder Type:
Major Depressive Disorder
Obsessive-Compulsive Disorder
Generalized Anxiety Disorder
Panic Disorder
Others

Breakup by Drug Type:
Generic Drugs
Branded Drugs

Breakup by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others

Breakup by Region:
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
Competitive Landscape:
The report has also analyzed the competitive landscape of the market with some of the key players being Otsuka Pharmaceutical, Pfizer, Eli Lilly and Company, AstraZeneca, Novartis, Bristol-Myers Squibb, GlaxoSmithKline, Takeda Pharmaceutical Company, Allergan, Johnson & Johnson, Zhejiang NHU Company Ltd, Sebela Pharmaceuticals, etc.

Key Questions Answered in This Report

1. What is the size of the global depression drugs market?
2. What has been the impact of COVID-19 on the global depression drugs market?
3. What is the expected growth rate of the global depression drugs market?
4. What are the key factors driving the global depression drugs market?
5. What is the breakup of the global depression drugs market based on the disorder type?
6. What is the breakup of the global depression drugs market based on the distribution channel?
7. What are the key regions in the global depression drugs market?
8. Who are the key companies/players in the global depression drugs market?

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Depression Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Drug Class
5.5 Market Breakup by Disorder Type
5.6 Market Breakup by Drug Type
5.7 Market Breakup by Distribution Channel
5.8 Market Breakup by Region
5.9 Market Forecast
6 Market Breakup by Drug Class
6.1 Atypical Antipsychotics
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Selective Serotonin Reuptake Inhibitors (SSRIs)
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Central Nervous System (CNS) Stimulants
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Tricyclic Antidepressants
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Monoamine Oxidase Inhibitors
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Others
6.7.1 Market Trends
6.7.2 Market Forecast
7 Market Breakup by Disorder Type
7.1 Major Depressive Disorder
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Obsessive-Compulsive Disorder
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Generalized Anxiety Disorder
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Panic Disorder
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Drug Type
8.1 Generic Drugs
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Branded Drugs
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Distribution Channel
9.1 Hospital Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Retail Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Online Pharmacies
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Europe
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Asia Pacific
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Middle East and Africa
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Latin America
10.5.1 Market Trends
10.5.2 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porter’s Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Otsuka Pharmaceutical
15.3.2 Pfizer
15.3.3 Eli Lilly and Company
15.3.4 AstraZeneca
15.3.5 Novartis
15.3.6 Bristol-Myers Squibb
15.3.7 GlaxoSmithKline
15.3.8 Takeda Pharmaceutical Company
15.3.9 Allergan
15.3.10 Johnson & Johnson
15.3.11 Zhejiang NHU Company Ltd
15.3.12 Sebela Pharmaceuticals

Figure 1: Global: Depression Drugs Market: Major Drivers and Challenges
Figure 2: Global: Depression Drugs Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Depression Drugs Market: Breakup by Drug Class (in %), 2022
Figure 4: Global: Depression Drugs Market: Breakup by Disorder Type (in %), 2022
Figure 5: Global: Depression Drugs Market: Breakup by Drug Type (in %), 2022
Figure 6: Global: Depression Drugs Market: Breakup by Distribution Channel (in %), 2022
Figure 7: Global: Depression Drugs Market: Breakup by Region (in %), 2022
Figure 8: Global: Depression Drugs Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 9: Global: Depression Drugs Industry: SWOT Analysis
Figure 10: Global: Depression Drugs Industry: Value Chain Analysis
Figure 11: Global: Depression Drugs Industry: Porter’s Five Forces Analysis
Figure 12: Global: Depression Drugs (Atypical Antipsychotics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Depression Drugs (Atypical Antipsychotics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Depression Drugs (Serotonin-Norepinephrine Reuptake Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Depression Drugs (Serotonin-Norepinephrine Reuptake Inhibitors) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Depression Drugs (Selective Serotonin Reuptake Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Depression Drugs (Selective Serotonin Reuptake Inhibitors) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Depression Drugs (Central Nervous System (CNS) Stimulants) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Depression Drugs (Central Nervous System (CNS) Stimulants) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Depression Drugs (Tricyclic Antidepressants) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Depression Drugs (Tricyclic Antidepressants) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Depression Drugs (Monoamine Oxidase Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Depression Drugs (Monoamine Oxidase Inhibitors) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Depression Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Depression Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Depression Drugs (Major Depressive Disorder) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Depression Drugs (Major Depressive Disorder) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Depression Drugs (Obsessive-Compulsive Disorder) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Depression Drugs (Obsessive-Compulsive Disorder) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Depression Drugs (Generalized Anxiety Disorder) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Depression Drugs (Generalized Anxiety Disorder) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Global: Depression Drugs (Panic Disorder) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Global: Depression Drugs (Panic Disorder) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Global: Depression Drugs (Other Disorder Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Global: Depression Drugs (Other Disorder Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Global: Depression Drugs (Generic Drugs) Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Global: Depression Drugs (Generic Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Global: Depression Drugs (Branded Drugs) Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Global: Depression Drugs (Branded Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: Global: Depression Drugs Market: Sales through Hospital Pharmacies (in Million US$), 2017 & 2022
Figure 41: Global: Depression Drugs Market Forecast: Sales through Hospital Pharmacies (in Million US$), 2023-2028
Figure 42: Global: Depression Drugs Market: Sales through Retail Pharmacies (in Million US$), 2017 & 2022
Figure 43: Global: Depression Drugs Market Forecast: Sales through Retail Pharmacies (in Million US$), 2023-2028
Figure 44: Global: Depression Drugs Market: Sales through Online Pharmacies (in Million US$), 2017 & 2022
Figure 45: Global: Depression Drugs Market Forecast: Sales through Online Pharmacies (in Million US$), 2023-2028
Figure 46: Global: Depression Drugs Market: Sales through Other Distribution Channels (in Million US$), 2017 & 2022
Figure 47: Global: Depression Drugs Market Forecast: Sales through Other Distribution Channels (in Million US$), 2023-2028
Figure 48: North America: Depression Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: North America: Depression Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Europe: Depression Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Europe: Depression Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Asia Pacific: Depression Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Asia Pacific: Depression Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Middle East and Africa: Depression Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Middle East and Africa: Depression Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Latin America: Depression Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Latin America: Depression Drugs Market Forecast: Sales Value (in Million US$), 2023-2028

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ うつ病治療薬の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測(Depression Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

うつ病治療薬の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp